Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

Item

http://www.wikidata.org/entity/Q34610473

Q34610473

about

Guidelines for the management of soft tissue sarcomas Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives The value of trabectedin in the treatment of soft tissue sarcoma Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment Trabectedin for advanced soft tissue sarcomas: optimizing use Current and future options in the management and treatment of uterine sarcoma Update on clinical research and state of the art management of patients with advanced sarcomas and GIST Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas UK guidelines for the management of soft tissue sarcomas Trabectedin in soft tissue sarcomas Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin Treatment of Adult Soft Tissue Sarcomas: An Overview Pazopanib in the treatment of soft tissue sarcoma Pazopanib, a new therapy for metastatic soft tissue sarcoma Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.The evolution of systemic therapy in sarcoma.Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma.Combination of trabectedin and gemcitabine for advanced soft tissue sarcomas: results of a phase I dose escalating trial of the German Interdisciplinary Sarcoma Group (GISG).Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group.A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.Operative and Conservative Treatment of Uterine Sarcomas Role of expert centres in the management of sarcomas Cost-effectiveness of pazopanib in advanced soft tissue sarcoma in the United kingdom.Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma.Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study.Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.Efficacy of trabectedin in patients with advanced or metastatic alveolar soft-part sarcoma.Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval.Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information.Liposarcoma in children and young adults: a multi-institutional experience.Trabectedin: safety and efficacy in the treatment of advanced sarcoma

P2860

Q21296866-31ED7DF4-3290-47B5-A81A-BB19069520A1 Q26738346-AC51D5D5-3F8B-41EA-AF99-26581CF5A8D7 Q26741817-9914BED0-90AF-4B21-AC2A-E6814D3B92D3 Q26745502-06B08FCF-B2B8-4C0A-9AC0-000B14E1154F Q26772855-59998D69-7842-46A6-BD4D-A49A45EC21BE Q26822530-90F0C8B4-838D-456C-8E46-E497DDB22805 Q26851658-18611BB4-B55B-412B-B27C-E7E73669651F Q26860365-AB0D5B89-08C4-4AB3-8B58-3B5D8245D7A7 Q27013559-EB79AF69-39E6-4D34-B1E6-A711ED56055F Q28073290-66A4DEDC-5477-4DBF-B8D8-4C25142A5C29 Q28076210-4187D58D-E390-46B1-80DD-1EB4F1297AB7 Q28076730-43401AB0-3DB7-4338-A7F0-863A089066C7 Q28085505-2B4AFC21-FA39-449A-9234-106819DCE857 Q28087771-2CF2803B-ED11-4300-8E86-7322895DBCBE Q28088685-C29D71C9-BB88-4A43-A8B3-CA0F68C4F062 Q28269229-2FC0334E-2A8A-48A9-830D-BF360848BA0A Q28287163-E4FC9BC9-0743-4FA2-8557-C826E78ED08D Q31124946-CC1F92EC-2B31-402B-9FDE-DD955C58DC08 Q33274710-86C17C21-055E-40A4-A8F3-DD5F6BE5111A Q33392364-E01B8FF6-6423-4231-9FFC-F036FA8FBCF7 Q33400959-64B70922-810E-40EC-AF43-34BC3F13C441 Q33419792-59931888-E2B8-4E32-9FD6-A50CB3B956B1 Q33426789-883BC5F1-5C64-40E9-979E-F8076077C03C Q33438485-E2BF237A-401C-4222-985B-D838A5B290EA Q33626132-C7EDB7F3-EF8F-4970-AD77-1DA259870F26 Q33697957-497DAE98-4941-4486-B5BC-2CF82D9FFC85 Q33850011-4DC20175-3433-4ECF-83F3-74BD54929074 Q33912177-48E1E734-6EC9-44EC-8645-01935B108634 Q33921802-3CCB88E6-1756-4F3A-BDB7-2491373E47AA Q34045393-E2714C31-CCB6-423B-BACF-FA7B5C04F155 Q34166391-8ADAD1FD-4D45-460B-889F-E0EFFAA97AFF Q34314062-83141919-5F51-4687-98FC-ACB577940AC0 Q34340390-78DA2F55-AEFB-4D9A-9324-0E251C23C5AE Q34356540-D859C469-4B44-4CAC-A73E-AB54ABAC55B0 Q34368039-E8142983-CA30-4C23-B777-0732C7A7837C Q34413670-16B0BE48-86F6-4AFF-AD68-B5B1515F65FE Q34578850-4C23E779-7926-4925-B1EF-0C079A34B707 Q34621474-2E1FF4B7-8649-432A-B4FD-7EB41541CC04 Q34627494-DAE36DF9-8E1E-46EA-AEBD-ED28F2AEDD59 Q34628607-CFA94D7F-BC34-46F5-AB35-FA250B77C6DF

P2860

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

Item

http://www.wikidata.org/entity/Q34610473

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue